Iodine-123-IBZM-SPECT: Studies in 15 patients with pituitary tumors
- 1 October 1994
- journal article
- clinical trial
- Published by Springer Nature in Journal of Neural Transmission
- Vol. 97 (3) , 235-244
Abstract
Summary Single photon emission computerized tomography (SPECT) using the Iodine 123 labeled dopamine D2 receptor antagonist S (−)Iodobenzamide [S (−)IBZM] was performed in 15 patients with pituitary tumors. Among them there were five prolactinoma patients with macroadenoma and two acromegalic patients with macroadenoma. Specific binding in the area of the adenoma was only observed in one subject, a macroprolactinoma patient, who was responsive to dopaminergic treatment. None of the other patients, among them one macroprolactinoma patient responsive to dopaminergic treatment showed specific binding in the area of the tumor. IBZM-binding in the striatum was found to be significantly lower in the group of pituitary tumor patients as compared to controls. The results show that D2 receptors in pituitary adenomas can be visualized using SPECT. However, the sensitivity of IBZM-SPECT appears to be too poor to visualize PRL- and GH- secreting macroadenomas in general.Keywords
This publication has 14 references indexed in Scilit:
- CV 205-502 in acromegalyEuropean Journal of Endocrinology, 1993
- Identification of extrastriatal dopamine D2 receptors in post mortem human brain with [125I]epideprideBrain Research, 1993
- Visualization of extrastriatal dopamine D2 receptors in the human brainEuropean Journal of Pharmacology, 1992
- Effects of the dopamine agonist CV 205-502 in human prolactinomas resistant to bromocriptine.The Journal of Clinical Endocrinology & Metabolism, 1992
- Dopamine, the dopamine D2 receptor and pituitary tumoursClinical Endocrinology, 1991
- Dopamine D2 Receptor Imaging with SPECT: Studies in Different Neuropsychiatric DisordersJournal of Cerebral Blood Flow & Metabolism, 1991
- A Randomized Study of SMS 201–995VersusBromocriptine Treatment in Acromegaly: Clinical and Biochemical EffectsThe Journal of Clinical Endocrinology & Metabolism, 1990
- Resistance to Bromocriptine in ProlactinomasThe Journal of Clinical Endocrinology & Metabolism, 1989
- Quantification of regional cerebral blood flow with IMP-SPECT. Reproducibility and clinical relevance of flow values.Stroke, 1989
- Evidence of Dopamine Receptors in Human Growth Hormone (GH)-Secreting Adenomas with Concomitant Study of Dopamine Inhibition of GH Secretion in a Perifusion System*The Journal of Clinical Endocrinology & Metabolism, 1982